How many puffs of intranasal midazolam spray (2.5 mg per puff) should be given to deliver 0.2 mg/kg without exceeding a total dose of 10 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intranasal Midazolam Dosing: Number of Puffs Required

For intranasal midazolam spray at 2.5 mg per puff, administer the number of puffs that delivers 0.2 mg/kg of the patient's body weight, with a maximum total dose of 10 mg (4 puffs maximum). 1

Calculating the Number of Puffs

To determine the exact number of puffs needed:

  • Calculate the target dose: Multiply the patient's weight in kg by 0.2 mg/kg 2, 3
  • Divide by 2.5 mg per puff to determine the number of puffs required 1
  • Round to the nearest practical puff increment (0.5 or whole puffs depending on device capability)
  • Never exceed 4 puffs total (10 mg maximum dose) 1

Practical Examples by Weight

  • 10 kg child: 0.2 mg/kg × 10 kg = 2 mg total dose ÷ 2.5 mg/puff = 0.8 puffs (round to 1 puff) 2
  • 20 kg child: 0.2 mg/kg × 20 kg = 4 mg total dose ÷ 2.5 mg/puff = 1.6 puffs (round to 1.5-2 puffs) 2
  • 30 kg child: 0.2 mg/kg × 30 kg = 6 mg total dose ÷ 2.5 mg/puff = 2.4 puffs (round to 2-2.5 puffs) 2
  • 40 kg child: 0.2 mg/kg × 40 kg = 8 mg total dose ÷ 2.5 mg/puff = 3.2 puffs (round to 3 puffs) 2
  • 50 kg or greater: 0.2 mg/kg would exceed 10 mg, so cap at 4 puffs (10 mg maximum) 1

Critical Dosing Context

The 0.2 mg/kg dose represents the lower end of the effective intranasal midazolam range and may provide inadequate sedation for some procedures. 2, 3

  • Recent high-quality evidence from a 2025 randomized trial demonstrated that 0.4-0.5 mg/kg intranasal midazolam are the optimal doses for procedural sedation in children undergoing laceration repair, with the 0.2 mg/kg dose being eliminated early in the adaptive trial for inadequate sedation 3
  • A 2012 study comparing 0.2 mg/kg versus 0.3 mg/kg found that at 20 minutes post-administration, only 63% of children receiving 0.2 mg/kg achieved adequate sedation compared to 76% receiving 0.3 mg/kg 2
  • If using 0.2 mg/kg, expect that 37-40% of patients may require supplemental sedation or have suboptimal procedural conditions 2, 3

Administration Technique

  • Divide the total dose between both nostrils when possible to improve absorption and tolerability 4
  • Use a volume of administration of 0.5 mL per nostril when feasible, as this provides optimal balance between rapid onset (4.3 minutes to minimal sedation) and clinician satisfaction with ease of administration 4
  • Avoid volumes less than 0.2 mL per nostril due to reduced clinician satisfaction with administration technique 4

Safety Monitoring Requirements

  • Continuous pulse oximetry is mandatory throughout the procedure and recovery period 5
  • Have flumazenil immediately available to reverse life-threatening respiratory depression 5
  • Monitor for respiratory depression, which can occur up to 30 minutes after administration 6
  • Paradoxical agitation occurs in approximately 6% of younger children receiving intranasal midazolam 6

Common Pitfall to Avoid

The most critical error is using 0.2 mg/kg when higher doses (0.4-0.5 mg/kg) are now supported by the strongest evidence for procedural sedation. 3 If institutional protocols mandate 0.2 mg/kg, be prepared with a rescue sedation plan for the 37-40% of patients who will have inadequate sedation at this dose 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.